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Objectives: To determine if there is a beneﬁcial effect of bariatric surgery in the management of Diabetes
Mellitus in obese patients in a Caribbean setting.
Methods: A retrospective review of charts of all obese patients with Type-2 Diabetes Mellitus (DM) who
had undergone Laparoscopic Roux en Y gastric bypass (LRYGBP) over a 4 year period was undertaken and
clinical data recorded. A questionnaire was prospectively administered via telephone to determine the
quality of life.
Results: Of 146 patients who underwent LRYGBP, 40 were found to have clinically signiﬁcant DM. Patients
of age < 50 years and females had a higher preponderance of DM. Patient body weight decreased
signiﬁcantly from a pre-operative131.2  21.6 [Mean  Standard Deviation (SD)] to 99.4  16.6 after
surgery (p < 0.0001). There was also a signiﬁcant reduction of BMI from 47.0  7.9 to 34.7  5.8
(p < 0.0001). There was complete resolution of clinically signiﬁcant DM in 85% of patients, while in 15%
there was a signiﬁcant reduction in the dosage of anti-diabetic medications. Perioperative complications
were minimal and there was no mortality. 96% of the patients reported a drastic improvement in their
quality of life.
Conclusions: Bariatric surgery for obese diabetic patients resulted in complete resolution, improved
diabetes control and overall improvement in the quality of life. Due to better outcomes, the surgery can
safely be recommended in the Caribbean multiethnic setting where there is a high prevalence of obesity
and Diabetes Mellitus.
 2011 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Morbid obesity is a causative factor for many life-threatening
co-morbidities including Type-2 Diabetes Mellitus (DM),
cardiovascular disease and cancer.1 Weight loss in these patients
has led to improvements in management of co-morbidities and
the inherent complications, resulting in reduced mortality.2
Bariatric surgery in the obese population with impaired glucose
tolerance (IGT) reduces the incidence of new onset diabetes by
58% and improves or resolves metabolic control of those with
established Type-2 DM.3 It has been shown that surgical treat-
ment for morbid obesity has been more effective in achieving
sustainable weight loss and resolving metabolic syndromes than
non-surgical methods.4 In addition, it is also noticed that
euglycaemia and normal insulin levels can occur within days
after surgery, long before there is sustainable weight loss raisingiharan).
ciates Ltd. Published by Elsevier Ltquestions as to the real mechanism of diabetic control after
bariatric surgery.5
Since July 2003, laparoscopic roux-en-Y gastric bypass (LRYGBP)
has been performed successfully in Trinidad. This study aims to
highlight the experiencewith bariatric surgery in a Caribbean island
(with 50% population belonging to Asian Indian descent) and to
examine whether bariatric surgery had a beneﬁcial effect on the
managementof Type-2DMwhich is highlyprevalent in this country.
Additional objectives of the study include determining whether
LRYGBPwasable toachieve sustainableweight loss in obesepatients
and also to determine if there was an overall improvement in the
quality of life in these patients after bariatric surgery.
2. Methods
After institutional approval, all patients with Type-2 Diabetes Mellitus who had
undergone LRYGBP from July 2006 to August 2010 and had at least 3 months of
follow-up were included in the study. Amongst the obese patients, only patients
who met the criteria for bariatric surgery based on the proposal of the National
Institutes of Health Consensus Conference Guidelines were selected for LRYGBP.d. All rights reserved.
Table 1
Demographic variables.
Age (y)
Range 23e59
Mean (Standard Deviation) 44 (10)
Gender Male (%) 40
Female (%) 60
Ethnicity East Indian descent (%) 47.5
African descent (%) 20
Mixed (%) 20
Other (%) 12.5
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Fig. 1. Distribution of comorbid illnesses. OSAS: Obstructive Sleep Apnoea
Syndrome, CVI: Chronic Venous Insufﬁciency, COPD: Chronic Obstructive Pulmonary
Disease, PCOS: Polycystic Ovarian Syndrome, RI: Renal Impairment, RA: Rheumatoid
Arthritis.
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Hypertension, Obstructive Sleep Apnoea (OSA) etc.
The diagnosis and classiﬁcation of DiabetesMellitus was based on the guidelines
established by the American Diabetic Association. The categories of fasting plasma
glucose (FPG) include
(1) FPG < 110 mg/dl (normal)
(2) FPG > 110 mg/dl and <126 mg/dl (impaired fasting glucose (IFG) or pre-
diabetes)
(3) FPG > 126 mg/dl (clinical diabetes).
In addition to 2 and 3 above, patients who were known to be Type-2 diabetics
on medication (even with a normal FPG prior to surgery) were included in the
study. The severity of diabetes mellitus was classiﬁed according to the treatment
required to maintain euglycaemia. Severity classiﬁcations included patients with
(1) Impaired fasting glucose
(2) Diet controlled DM
(3) Oral hypoglycaemic controlled DM
(4) Insulin controlled DM
(5) Combination of insulin and oral agents to control DM.
All patients underwent a rigorous pre-operative work-up which included
a history and physical examination, nutritional and psychological evaluation and
counselling, cardiology and endocrinology evaluation.
The bariatric surgical procedures were performed by the same surgeon (ﬁrst
author) using a standard six port technique. Under general anaesthesia, after
pneumoperitoneum, the dissection started with identiﬁcation of the angle of His.
The gastric pouch was then created by transection of the stomach with linear
staplers (Ethicon ) to create a pouch averaging 15e30 cc. The length of the Roux
limb varied from 100 to 200 cm and the bilio pancreatic limb was 50 cm. The
gastro-jejunal anastomosis was created with a linear stapler to a length of
10e15 mm and this anastomosis was routinely tested to ensure that it was both
air and water tight. It was done in an antecolic and antegastric fashion.
Estimation of blood sugar was done every 6 h while in the hospital and
patients were given insulin as needed. The patients were discharged on the
second post-operative day once they tolerated oral feeds and were advised
a 600 kcal liquid diet. On discharge, patients were advised to check the blood
sugars at least twice daily and to restart medications only if the sugars were
persistently above 150 mg/dl. The ﬁrst three follow-ups following surgery were
done at the surgical clinic and thereafter followed up at 2 weeks, then 6 weeks
and then every 12 weeks in diabetic clinics. The dose of restarted medications,
if any, was adjusted down to the least necessary for euglycaemia to prevent
hypoglycaemia. HbA1C levels were done, if control was a problem. Physical
exercise was started by two weeks.
Demographic and clinical data were recorded retrospectively from charts.
Demographic data included age, gender, ethnicity of the patients and clinical data
included diabetic status, co-morbidities, surgical procedure and duration, pre-oper-
ative andpost-operativeanthropometry includingbodyweight (kg) andBMI (kg/m2).
A quality of life assessment was done via telephone using a self-designed
questionnaire (Appendix). In this questionnaire, the questions pertaining to
quality of life assessment alone were adapted from the well established SF-32
questionnaire. A ﬁve-point Likert scale ranging from 1 (poor) to 5 (excellent)
was used to evaluate the quality of life and social and emotional status.
Data were entered into Statistical Package for Social Sciences (SPSS)dversion 12
(Chicago, IL, USA) and analysed. Descriptive analyses of all data were done. For
numerical data such as body weight and BMI, comparisons were made between pre-
operative and post-operative periods by ‘Paired t-tests’. Categorical and ordinal data
were compared by Chi-square analyses. Statistical signiﬁcance was ﬁxed at the level of
p < 0.05.
3. Results
One hundred and forty six patients had LRYGBP performed
during the study period from July 2006 through August 2010. Of
these, 40 (27.4%) patients were found to have clinically signiﬁcant
DM. 42.5% of the diabetic patients were above the age of 50 years
and 57.5% were between ages 18e49 years. The gender distribution
showed preponderance for females, accounting for 60% of the
patients. The ethnic composition of the study group reﬂected
the general population of the island with the majority being
Indo-Trinidadians. Table 1 depicts the demographic variables. Fig. 1
shows the distribution of comorbid illnesses.
Patients belonged to all categories according to the severity of
DM. Diabetes was present for less than 5 years in 26 (64%) of thepatients prior to surgery. Over 90% of these patients were
compliant with their medications; however, diabetes control was
only achieved in 58% of these patients as revealed by HbA1C
measurements and daily glucometer readings.
Pre-operatively the body weight of the patients ranged from
90 to 177 kg with a mean of 131.2 kg (Standard Deviation (SD),
21.6). The BMI ranged from 34.9 to 64.8, with a mean of 47.0
(SD 7.9). 96% of these patients had BMI > 35. Post-operatively,
the weight loss ranged from 21.3 to 72.7 kg with a mean of 37.3
(SD 10.5) kg. The comparisons between the pre-operative and
post-operative parameters are shown in Table 2. The time period
of patient follow-up ranged from 3 to 50 months with a mean
of 15 months. The change in the BMI between pre-operative
and post-operative periods in the different diabetic categories is
shown in Fig. 2.
Post-operatively, there was a drastic change in blood glucose
control. The changes were noted in the immediate post-operative
period and progressively improved over time. Thirty of the
40 patients were never restarted on medications in the immediate
post-operative periodwhile 10 required some formof control (either
insulin or metformin). Four of these patients resolved completely by
1 month and 6 remained on medications. Thus, there was complete
resolution of clinically signiﬁcant DM in 34 (85%) of these patients
and a signiﬁcant reduction in the number and dosage ofmedications
to controlDM in the remaining6 (15%). In one of these latter patients,
before undergoing surgery, the daily medications to control DM
included 450 units insulin combined with 2 oral agents. Within one
month after surgery, the patient had adequate blood sugar control
withmetformin only. The other 5 patients were also controlled with
metformin alone post-operatively. The comparison of interventions
Table 2
Comparison of variables before and after surgery.
Variable Before surgery After surgery Signiﬁcance
Body weight
(Mean  SD)
131.2  21.6 99.4  16.6 p < 0.0001*
BMI
(Mean  SD)
47.0  7.9 34.7  5.8 p < 0.0001*
Number of patients on
insulin (%)
27.5 2.5 p < 0.001x
Number of patients on
metformin (%)
42.5 12.5 p < 0.001x
Quality of life score 3 5 p < 0.01x
*Statistical signiﬁcance by paired t-tests.
xStatistical signiﬁcance by Chi-square tests.
Table 3
Comparison of interventions for DM before and after surgery.
Severity of DM Pre-operative
n (%)
Post-operative
n (%)
Impaired glucose tolerance
without overt DM
9 (22.5) 0
DM controlled by diet
and exercise
3 (7.5) 0
DM controlled by oral
hypoglycaemic agents
17 (42.5) 5 (12.5)
DM controlled by insulin 6 (15) 1 (2.5)
DM controlled by insulin
and oral hypoglycaemic agents
5 (12.5) 0
Euglycaemia post-operatively
not requiring any intervention
0 34 (85)
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diabetic categories is shown in Table 3.
Therewas nomortality in this study. Perioperative complications
were limited to the occasional dumping syndrome andmild hair loss.
There were no surgical complications such as leaks, infections or
reoperation or other major morbidities such as DVT or pulmonary
embolism in this cohort. One patient hadmild chest painwhich was
thought to be coronary spasm syndrome and this settled unevent-
fully. Another patientwas diagnosed to have aspirationpneumonitis,
needed readmission but settled with conservative management.
The quality of life assessment showed that 60% of patients
graded their quality of life in the pre-operative period as either
2 or 3; in the post-operative period all but one patient graded
their quality of life as 5 (excellent) (p < 0.01 by Chi-square test)
(Table 2), implying overall satisfaction with the surgery.4. Discussion
The major ﬁnding of the present study is the ability of bariatric
surgery to adequately control Type-2 Diabetes Mellitus and to
improve of the quality of life in obese patients in a Caribbean setting.
The global epidemic of Type-2 DM and obesity has afﬂicted the
Caribbean region also.5e7 Globally, approximately 150 million
individuals are currently affected by Type-2 DM and it is estimated
that by 2025, this may increase to 300 million.8,9 Type-2 DM0
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Fig. 2. Change in BMI in the different diabetic groups I: Impaired glucose tolerance
without overt DM, II: DM controlled by diet and exercise, III: DM controlled by oral
hypoglycaemic agents, IV: DM controlled by insulin, V: DM controlled by insulin and
oral hypoglycaemic agents.increases morbidity and mortality and is an economic burden on
health budgets worldwide. Weight loss has been consistently
associated with a better control of diabetes. The incidence of
complications of Type-2 DM can be reduced with tight euglycaemic
control using medical management, diet and exercise. However,
compliance has been a major impediment to medical management,
and seldom results in complete resolution.
The mounting evidence for surgery as a potential cure for Type-
2 DM comes from observations of the resolution of Type-2 DM after
bariatric surgery for morbid obesity, gastric surgery for gastric
carcinoma, experimental evidence from rodents, human evidence
and on-going trials on humans.10 The present study supports the
evidence for the resolution of Type-2 DM after bariatric surgery in
the Caribbean.
Bariatric surgery has a profound and durable effect on the
resolution of Type-2 DM. In a meta-analysis of 134 studies, Buch-
wald et al reported varying percentages of Type-2 DM resolution
following different types of bariatric surgery; 48% for laparoscopic
adjustable gastric banding, 84% for gastric bypass and 98% for Bilio
Pancreatic Diversion/Duodenal (BPD) Switch.11
Gastric bypass surgery decreases both the incidence and preva-
lence of Type-2 DM in patients. This resolution occurs within days
after gastric bypass, before any signiﬁcant weight loss and was sus-
tained for a longer time period. Pories et al reported the long term
results of 608 severely obese patientswho underwent gastric bypass,
witha93% follow-upover14years.12Of the146patientswithbaseline
DM, 83% continued to be normoglycaemic at 14 years. Glucose levels
normalized within a few days after surgery, before signiﬁcant weight
loss occurred which was a ﬁnding in the present study also.
Bariatric surgery prevents the progression from impaired
glucose tolerance to diabetes and hence reduces the incidence of
Type-2 DM. Pories et al demonstrated resolution of glucose intol-
erance in 98.7% of patients undergoing gastric bypass.12 In the
Swedish Obesity Subjects trial, which compared the outcomes of
surgical versus medical management of 4047 obese patients over
a 10 year period, there was a reduction of 30 in the relative risk for
developing Type-2 DM in the surgical arm.4 In a Caribbean setting
where there is high prevalence of Type-2 DM, this can actually
change epidemiological characteristics.
Although weight loss was initially believed to be responsible
for diabetic control following bariatric surgery, it was realized
that gastric bypass resolved DM even before any signiﬁcant weight
loss occurred, whichwas a ﬁnding in the present study also. This has
led to the postulation of the foregut and hindgut theories. Numerous
othermetabolites (including ghrelin) are also being investigated.13,14
The foregut theory suggests that the exclusion of a short
segment of the proximal small intestine from ingested nutrients
exerts a direct anti-diabetic effect. Rubino demonstrated that
a duodeno-jejunal bypass in rats improved diabetic control.15 These
results have been reproduced in human studies of duodenal-jejunal
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and non-obese.16
The hindgut theory suggests that after LRYGB, bilio pancreatic
diversion (BPD) and ileal transposition, expedited delivery of
ingested nutrients to the lower intestine increases the secretion of
Glucagon like peptide (GLP-1). This is an incretin that lowers blood
sugar. GLP-1 is increased after the above two procedures but not
after gastric banding.17,18
In 2009, the American Diabetic Association (ADA) recom-
mended that patients with a BMI > 35 and Type-2 DM should be
considered for bariatric surgery due to growing evidence that
various gastrointestinal (GI) operations were being used
throughout the world to treat obese and non-obese diabetics with
resounding results.19,20 The consensus statement of the ﬁrst Dia-
betes Surgery Summit, 2007 also suggested that GI surgery should
be considered for the treatment of Type-2 DM in eligible surgical
candidates with BMI < 35 who are inadequately controlled by
lifestyle and medical therapy.21 In our study, 96% of the patients
had BMI above 35 and hence ﬁt the above criteria. In fact, the effects
of bariatric procedures on DM control and resolution are so
profound that the ﬁeld of ‘metabolic surgery’ is emerging exclu-
sively to treat DM. In our study, 85% of our patients had complete
resolution of their diabetes mellitus and the remaining 15% had
a drastic improvement in their control.
It has been shown that the phenotypic makeup of the Asian
population is different to that of their Caucasian counterparts and
that the deﬁnition of obesity in this ethnic group should be
different. Additionally, the Asian population is prone to high levels
of metabolic risk factors at a relatively low BMI and this phenom-
enon may be attributable to the fact that Asians are more prone to
central obesity. This trend includes Asian Indians, who form amajor
proportion of the Caribbean population.22,23 Body fat of more than
25% in males and 35% in females is considered ‘Excessive Body
Fat’.24 Studies suggest that the percentage of Excessive Body Fat
was under-predicted by BMI in the Asian population.25
As a result of these differences, the ﬁrst Asian Consensus
Meeting on Metabolic Surgery, 2008 formulated guidelines for the
use of surgery for Type-2 DM in the Asian population.26 These
guidelines have taken into consideration the unique differences
with respect to BMI and central obesity prevalent in this ethnicgroup. A high percentage of population in many Caribbean coun-
tries belong to the Asian Indian ethnicity which is especially true in
Trinidad & Tobago and Guyana. This ethnic group in the Caribbean
is unique in that they possess the ‘Asian Indian’ body habitus but
consume mainly a ‘Western’ diet. This has resulted in a high
prevalence of obese diabetics with early complications. This is also
compounded by poor compliance with medical management and
poor social service support, causing a strain on the health sector
and a negative economic spin-off.27 Type-2 DM and obesity are
highly prevalent in the Caribbean society and their impact on
increased mortality is well documented especially in those of the
Asian Indian descent.28 A vast majority of the patients in our study
belonged to this ethnicity. The possibility of using bariatric surgery
at a relatively lower BMI to treat and cure Type-2 DM may have
a greater economic impact on the Caribbean society.
There were many limitations to the study; the major limitations
beingretrospectivedesign,a relativelysmaller samplesizeand inability
to correlate severity of diabetes with variations in surgical procedure
and overall outcomes. The questionnaire was a self-designed one,
although the ‘quality of life’ part was adapted from an established
validated questionnaire. The telephone interview is another limitation
and there is a possibility that this would not have captured sufﬁcient
information similar to that of a face-to-face interview.
Nevertheless, in summary, the study was able to establish that
bariatric surgery could be safely performed in the Caribbean envi-
ronment and may result in an overall improvement in quality of
life. The Asian ethnic group in the Western world is a special group
and the indications for metabolic surgery may have to be tailored
for this population.
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